SH3BGRL2

Model summary

A predominantly cytoplasmic, acidic adaptor that uses a thioredoxin-like scaffold to organize protein–protein assemblies controlling translation initiation and protein quality control. By presenting a glutamate-rich binding surface, it recruits initiation factors and signaling adaptors to stimulate assembly of initiation complexes while coupling to ubiquitin–proteasome pathways for selective degradation. A minor pool operates within the nucleoplasm and at the nuclear membrane, consistent with transient roles at the nuclear periphery where mRNP export and proteostasis intersect.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   The sequence is entirely covered by IPR036249 (Thioredoxin-like superfamily, residues 1–107), indicating a compact α/β thioredoxin-like fold that often serves as a stable protein–protein interaction scaffold rather than an enzyme when canonical redox motifs are absent. Superimposed on this fold are two family-level signatures—IPR006993 (SH3-binding, glutamic acid-rich protein family, residues 1–104) and IPR051033 (SH3 domain-binding glutamic acid-rich protein family, residues 1–104)—which specify a glutamate-enriched, acidic surface adapted to engage SH3-domain-containing partners. The coextensive coverage of these families across the full length argues that the thioredoxin-like core is functionally repurposed as an adaptor platform. This architecture causes broad, multivalent protein binding rather than catalysis, aligning with GO:0005515 protein binding as the primary molecular function.

2. 02

   From this scaffolded binding capacity, I infer two connected biological roles.

   First, the acidic adaptor surface can recruit translation machinery and initiation factors at the cytoplasmic face of membranes or within ribonucleoprotein assemblies, thereby enhancing assembly and throughput of initiation complexes. This mechanistic role supports GO:0045948 positive regulation of translational initiation. Second, the same adaptor properties enable assembly of ubiquitin–proteasome pathway components, steering substrate selection and handoff to the proteasome. Such coupling between initiation control and protein quality surveillance explains participation in GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process.

3. 03

   Cellular localization follows from how and where such assemblies operate.

   The thioredoxin-like scaffold and SH3-binding propensity favor peripheral association with membrane-proximal signaling hubs and cytoplasmic complexes. The reported distribution—predominantly cytoplasmic with a minor nuclear pool—fits this logic. The cytoplasmic enrichment positions the protein to modulate translation and proteostasis near ribosomes and the proteasome. The minor nuclear fraction and its enrichment in the nucleoplasm (GO:0005654) and at the nuclear membrane (GO:0031965) suggest transient roles at the nuclear periphery, where mRNP export and quality-control checkpoints converge. Together, these observations support a soluble cytoplasmic baseline with regulated excursions to nuclear compartments.

4. 04

   Mechanistically, I propose that the thioredoxin-like core provides a rigid platform that concentrates SH3-domain partners and initiation factors to stimulate translation initiation while simultaneously sampling ubiquitinated substrates for proteasomal turnover.

   At the nuclear periphery, the same scaffold likely coordinates assembly of transport and surveillance complexes. Likely interaction partners include SH3-domain adaptors and translation-initiation modules that dock to acidic adaptor surfaces, as well as proteasome and ubiquitin-pathway components that couple to translational control circuits.